title: Potential bias in Kaplan-Meier survival analysis applied to rheumatology drug studies.
authors.forename: M
authors.initials: M
authors.lastname: Utley
authors.forename: S
authors.initials: S
authors.lastname: Gallivan
authors.forename: A
authors.initials: A
authors.lastname: Young
authors.forename: N
authors.initials: N
authors.lastname: Cox
authors.forename: P
authors.initials: P
authors.lastname: Davies
authors.forename: J
authors.initials: J
authors.lastname: Dixey
authors.forename: P
authors.initials: P
authors.lastname: Emery
authors.forename: A
authors.initials: A
authors.lastname: Gough
authors.forename: D
authors.initials: D
authors.lastname: James
authors.forename: P
authors.initials: P
authors.lastname: Prouse
authors.forename: P
authors.initials: P
authors.lastname: Williams
authors.forename: J
authors.initials: J
authors.lastname: Winfield
authors.forename: J A
authors.initials: JA
authors.lastname: Devlin
mesh_terms: D018501:Antirheumatic Agents / Q000627:therapeutic use*; D006801:Humans; D012216:Rheumatic Diseases / Q000188:drug therapy*; D012219:Rheumatology / Q000379:methods*; D012460:Sulfasalazine / Q000627:therapeutic use; D016019:Survival Analysis
chemical_list: D018501:Antirheumatic Agents; D012460:Sulfasalazine